Cardio Diagnostics (CDIOW) Competitors $0.01 +0.00 (+1.37%) As of 08/15/2025 12:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock CDIOW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CELUW, CEROW, CINGW, CLNNW, and COEPWShould you be buying Cardio Diagnostics stock or one of its competitors? The main competitors of Cardio Diagnostics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), Clene (CLNNW), and Coeptis Therapeutics (COEPW). These companies are all part of the "biotechnology" industry. Cardio Diagnostics vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Celularity CERo Therapeutics Cingulate Clene Coeptis Therapeutics Cardio Diagnostics (NASDAQ:CDIOW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends. Does the media prefer CDIOW or ATNFW? In the previous week, 180 Life Sciences had 3 more articles in the media than Cardio Diagnostics. MarketBeat recorded 5 mentions for 180 Life Sciences and 2 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.44 beat 180 Life Sciences' score of 1.01 indicating that Cardio Diagnostics is being referred to more favorably in the media. Company Overall Sentiment Cardio Diagnostics Positive 180 Life Sciences Positive Which has better valuation & earnings, CDIOW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCardio Diagnostics$19.90KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is CDIOW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Cardio DiagnosticsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryCardio Diagnostics beats 180 Life Sciences on 2 of the 3 factors compared between the two stocks. Get Cardio Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for CDIOW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CDIOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDIOW vs. The Competition Export to ExcelMetricCardio DiagnosticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$138.55M$5.67B$9.82BDividend YieldN/A3.74%3.79%4.07%P/E RatioN/A3.8230.5825.12Price / SalesN/A4,361.86460.38114.01Price / CashN/A13.1937.4059.05Price / BookN/A44.949.096.18Net IncomeN/A-$90.99M$3.25B$264.89M7 Day PerformanceN/A1.65%7.42%4.22%1 Month PerformanceN/A4.88%5.50%2.02%1 Year PerformanceN/A191.26%30.67%24.22% Cardio Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDIOWCardio DiagnosticsN/A$0.01+1.4%N/A-63.0%$0.00$19.90K0.007Positive NewsShort Interest ↓Gap UpATNFW180 Life SciencesN/A$0.01+1.0%N/A+4,157.4%$0.00N/A0.007News CoverageGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.06-44.7%N/A+95.7%$0.00$665.45K0.002DRTSWAlpha Tau MedicalN/A$0.27-0.4%N/AN/A$0.00N/A0.0080News CoverageAPLMWApollomicsN/A$0.03+16.3%N/A+60.4%$0.00N/A0.0059Short Interest ↓BCTXWBriaCell TherapeuticsN/A$0.03-27.9%N/A-87.6%$0.00N/A0.008Negative NewsShort Interest ↓Gap DownHigh Trading VolumeCELUWCelularityN/A$0.05flatN/A+150.0%$0.00$54.22M0.00220News CoveragePositive NewsGap DownCEROWCERo TherapeuticsN/A$0.02-0.5%N/AN/A$0.00N/A0.008Gap DownCINGWCingulateN/A$0.06-51.1%N/A+164.6%$0.00N/A0.0020High Trading VolumeCLNNWCleneN/A$0.04-6.4%N/A-27.3%$0.00$350K0.00100COEPWCoeptis TherapeuticsN/A$0.02-13.6%N/A+16.0%$0.00$62.87K0.004Gap Down Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors APLMW Competitors BCTXW Competitors CELUW Competitors CEROW Competitors CINGW Competitors CLNNW Competitors COEPW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDIOW) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardio Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access